For citations:
Shikaleva AA, Maximov ML, Kiseleva NM. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the treatment of dyslipidemia. Meditsinskiy sovet = Medical Council. 2020;(21):12-18. (In Russ.) https://doi.org/10.21518/2079-701X-2020-21-12-18